Identified a key protein in the generation of B lymphocytes
Hematopoietic System Repression of “inappropriate” genes Article’s reference
Identified a key protein in the generation of B lymphocytes Read More »
Hematopoietic System Repression of “inappropriate” genes Article’s reference
Identified a key protein in the generation of B lymphocytes Read More »
A study published in Journal of Investigative Dermatology has identified a potential therapeutic target for the treatment of psoriasis, a chronic inflammatory disease of the skin that affects up to a 2% of the population and which has still no cure. The study shows that the TREX2 gene has a relevant role in the inflammatory
Researchers identify a key molecule in psoriasis development Read More »
On October 12th, the Mediterranean Marathon, one of the consolidated sports programming dating in the country, reaches its XII edition. Under the slogan “Do not run, fly!” participants in the race can make, voluntarily and for the first time in the history of this competition, a charitable contribution to a research project of the Bellvitge
The XII Mediterranean Marathon will run to overcome autoimmune diseases Read More »
From today until next Friday, the business development & innovation area of IDIBELL will participate in the eighth edition of Biospain 2016 , the most important biotech event in southern Europe
IDIBELL presents its technology portfolio in Biospain 2016 Read More »
Humans can learn effectively, especially when they are externally rewarded (for example, with money or desirable incentives after their actions). Instead of externally-triggered learning (carrot-based learning), self-organised or intrinsically driven learning refers to those learning processes without any objective reward. If you think of it, humans are often involved in these types of rewardless learning
An article published in the journal Human Genetics by Manel Esteller, Director of the Program for Epigenetics and Cancer Biology (PEBC) of Bellvitge Biomedical Research Institute (IDIBELL), ICREA researcher and Professor of Genetics of the University of Barcelona, discovers mutations in genes associated with the development of atypical Rett syndrome, and distinguishes this clinical entity
Scientists find mutations associated with unusual forms of Rett syndrome Read More »
The research deals with functional studies of genes linked to a type of inherited blindness in order to identify potential therapeutic targets
ONCE and IDIBELL working together in a Project on Retinitis Pigmentosa Read More »
Researchers at the Bellvitge Biomedical Research Institute (IDIBELL), led by Dr. Montse Sanchez-Cespedes, have demonstrated in in vitro and in vivo studies the effectiveness of a new drug combination in the treatment of a subtype of lung cancer. The study, published by the journal Oncogene, follows a promising lead for a disease for which there
Today September 20th, Ms. Magda Martí has been officially presented as the new Managing Director of IDIBELL to all administration and service staff. Martin joined IDIBELL last September 12th replacing Mr. Alexandre Puerto. Magda Martí comes from the Quality and Health Assessment Agency of Catalonia (AQuAS), where she worked for more than eight years as
Magda Martí, new managing director of IDIBELL Read More »
INPhINIT a new doctoral fellowship programme international Early-Stage Researchers supporting the best scientific talent fostering innovative and high-quality research in Spain 57 Early-Stage Researchers of any nationality, 3-year employment contract at the Research Centre of their choice personal career development plan mobility opportunities, complementary training courses and workshops. European Commission’s support Horizon 2020 Marie Skłodowska-Curie Actions – COFUND programme highest standards for research training
INPhINIT, the new ”la Caixa” Doctoral Fellowship Programme Read More »